The pharmacovigilance program on natalizumab in Italy: 2 years of experience
- 1 October 2009
- journal article
- ms treatment
- Published by Springer Nature in Neurological Sciences
- Vol. 30 (2) , 163-165
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2006
- Natalizumab plus Interferon Beta-1a for Relapsing Multiple SclerosisNew England Journal of Medicine, 2006
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992